NO304888B1 - Quaternary basic amides and pharmaceutical mixtures containing them - Google Patents

Quaternary basic amides and pharmaceutical mixtures containing them

Info

Publication number
NO304888B1
NO304888B1 NO933481A NO933481A NO304888B1 NO 304888 B1 NO304888 B1 NO 304888B1 NO 933481 A NO933481 A NO 933481A NO 933481 A NO933481 A NO 933481A NO 304888 B1 NO304888 B1 NO 304888B1
Authority
NO
Norway
Prior art keywords
group
alkyl
omega
optionally substituted
image
Prior art date
Application number
NO933481A
Other languages
Norwegian (no)
Other versions
NO933481L (en
NO933481D0 (en
Inventor
Xavier Emonds-Alt
Patrick Gueule
Vincenzo Proietto
Didier Van Broeck
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO933481D0 publication Critical patent/NO933481D0/en
Publication of NO933481L publication Critical patent/NO933481L/en
Publication of NO304888B1 publication Critical patent/NO304888B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)

Abstract

The invention relates to basic quaternary amides of formula <IMAGE> in which - Ar represents an optionally substituted mono-, di- or tricyclic heteroaromatic or aromatic group; - T represents a direct bond, a hydroxymethylene group, an alkoxymethylene group in which the alkoxy group is C1-C4 or a C1-C5 alkylene group; - Ar' represents a phenyl which is unsubstituted or substituted one or a number of times, a thienyl, a benzothienyl, a naphthyl or an indolyl; - R represents hydrogen, a C1-C4 alkyl, an omega -(C1-C4)alkoxy(C2-C4)alkyl or an omega -(C1-C4)alkanoyloxy(C2-C 4)alkyl, - Q represents hydrogen; - or else Q and R, together, form a 1,2-ethylene, 1,3-propylene or 1,4-butylene group; - Am<(+)> represents the radical <IMAGE> in which X1, X2 and X3, together and with the nitrogen atom to which they are bonded, form an azabicyclic or azatricyclic system optionally substituted by a phenyl group; - A<(-)> is a pharmaceutically acceptable anion. These compounds are useful in the preparation of medicaments intended for the treatment of pathologies involving the tachykinin system.
NO933481A 1992-09-30 1993-09-29 Quaternary basic amides and pharmaceutical mixtures containing them NO304888B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9212083A FR2696178B1 (en) 1992-09-30 1992-09-30 Quaternary basic amides, process for their preparation and pharmaceutical compositions containing them.

Publications (3)

Publication Number Publication Date
NO933481D0 NO933481D0 (en) 1993-09-29
NO933481L NO933481L (en) 1994-04-05
NO304888B1 true NO304888B1 (en) 1999-03-01

Family

ID=9434374

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933481A NO304888B1 (en) 1992-09-30 1993-09-29 Quaternary basic amides and pharmaceutical mixtures containing them

Country Status (27)

Country Link
EP (1) EP0591040B1 (en)
JP (2) JP2857041B2 (en)
KR (1) KR100279084B1 (en)
CN (1) CN1036652C (en)
AT (1) ATE176469T1 (en)
AU (1) AU674875B2 (en)
BR (1) BR9303982A (en)
CA (1) CA2107432C (en)
CZ (1) CZ287272B6 (en)
DE (1) DE69323375T2 (en)
DK (1) DK0591040T3 (en)
ES (1) ES2130238T3 (en)
FI (1) FI114474B (en)
FR (1) FR2696178B1 (en)
GR (1) GR3030000T3 (en)
HU (2) HU215848B (en)
IL (1) IL107158A0 (en)
MX (1) MX9306024A (en)
MY (1) MY108881A (en)
NO (1) NO304888B1 (en)
NZ (1) NZ248821A (en)
OA (1) OA09869A (en)
RU (1) RU2120436C1 (en)
SG (1) SG47807A1 (en)
SI (1) SI9300513B (en)
TW (1) TW242625B (en)
ZA (1) ZA937276B (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583134A (en) * 1992-09-30 1996-12-10 Sanofi 1-azoniabicyclo[2.2.2] octanes and pharmaceutical compositions in which they are present
FR2717802B1 (en) * 1994-03-25 1996-06-21 Sanofi Sa New aromatic compounds, process for their preparation and pharmaceutical compositions containing them.
FR2717804B1 (en) * 1994-03-25 1996-06-21 Sanofi Sa Salts of substituted nitrogen heteroaromatic compounds, process for their preparation and pharmaceutical compositions containing them.
NZ270985A (en) 1994-04-29 1997-06-24 Lilly Co Eli Substituted benzimidazole derivatives; medicaments and preparation of medicaments
PL180866B1 (en) 1994-07-12 2001-04-30 Lilly Co Eli Heterocyclic antagonists of tachykinin receptors
FR2725900B1 (en) * 1994-10-21 1997-07-18 Sanofi Sa USE OF NK1 RECEPTOR ANTAGONISTS FOR THE PREPARATION OF DRUGS WITH CARDIOREGULATORY ACTION
US6008223A (en) * 1994-10-27 1999-12-28 Zeneca Limited Therapeutic compounds
GB9421709D0 (en) * 1994-10-27 1994-12-14 Zeneca Ltd Therapeutic compounds
CA2162786A1 (en) * 1994-11-22 1996-05-23 Philip Arthur Hipskind Heterocyclic tachykinin receptor antagonists
FR2751654B1 (en) * 1996-07-26 1998-10-23 Sanofi Sa SUBSTITUTED HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2729954B1 (en) * 1995-01-30 1997-08-01 Sanofi Sa SUBSTITUTED HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2729952B1 (en) * 1995-01-30 1997-04-18 Sanofi Sa SUBSTITUTED HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2729951B1 (en) * 1995-01-30 1997-04-18 Sanofi Sa NOVEL HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
US5654316A (en) * 1995-06-06 1997-08-05 Schering Corporation Piperidine derivatives as neurokinin antagonists
EP0848706B1 (en) * 1995-06-06 2003-02-05 Schering Corporation Substituted benzene-fused heterocyclics as neurokinin antagonists
FR2745811B1 (en) * 1996-03-07 1998-05-22 Sanofi Sa DISSUBSTITUTED GLUTARIMIDE PROCESS FOR ITS PREPARATION, AND ITS USE
CA2255910A1 (en) * 1996-05-24 1997-11-27 Mitchell Irvin Steinberg Methods of treating hypertension
US5691362A (en) * 1996-06-05 1997-11-25 Schering-Plough Corporation Substituted benzene-fused hetero- and carbocyclics as nuerokinin antagonists
GB9617730D0 (en) * 1996-08-23 1996-10-02 Pfizer Ltd Quarternary ammonium compounds
FR2759585B1 (en) 1997-02-17 1999-06-11 Sanofi Sa PHARMACEUTICAL FORMULATIONS PRESENTED IN A DRY FORM FOR THE ORAL ADMINISTRATION OF A CYCLIC QUATERNARY AMMONIUM COMPOUND
FR2759584B1 (en) * 1997-02-17 1999-06-11 Sanofi Sa PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF HETEROCYCLIC COMPOUNDS IN QUATERNARY AMMONIUM FORM
AU744261B2 (en) * 1997-04-24 2002-02-21 Merck Sharp & Dohme Limited Use of NK-1 receptor antagonists for treating eating disorders
GB9712882D0 (en) 1997-06-18 1997-08-20 Pfizer Ltd Quaternary ammonium compounds
GB9716463D0 (en) * 1997-08-04 1997-10-08 Merck Sharp & Dohme Therapeutic agents
GB9716457D0 (en) * 1997-08-04 1997-10-08 Merck Sharp & Dohme Therapeutic agents
AU738047B2 (en) * 1997-08-04 2001-09-06 Merck Sharp & Dohme Limited Use of NK-1 receptor antagonists for treating mania
CA2298779A1 (en) * 1997-08-04 1999-02-18 Merck Sharp & Dohme Limited Use of nk-1 receptor antagonists for treating aggressive behaviour disorders
GB9816897D0 (en) * 1998-08-04 1998-09-30 Merck Sharp & Dohme Therapeutic use
GB9927125D0 (en) 1999-11-16 2000-01-12 Univ Reading The Placental human neurokinin B precursor
CN1942441A (en) * 2004-02-25 2007-04-04 三共株式会社 Sulfonyloxy derivatives
JP2008534504A (en) 2005-03-22 2008-08-28 アゼヴァン ファーマスーティカルズ，インコーポレイテッド Β-Lactamyl alkanoic acid for treating premenstrual disorders
ES2726942T3 (en) 2005-07-19 2019-10-10 Azevan Pharmaceuticals Inc Vasopressin antagonist of beta-lactam phenylalanine, cysteine and serine type
EA200970706A1 (en) 2007-01-24 2010-02-26 Глэксо Груп Лимитед NEW PHARMACEUTICAL COMPOSITIONS
UA105182C2 (en) 2008-07-03 2014-04-25 Ньюрексон, Інк. Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
ES2662350T3 (en) 2010-07-01 2018-04-06 Azevan Pharmaceuticals, Inc. Procedures for the treatment of posttraumatic stress disorder
BR112016022575A2 (en) 2014-03-28 2017-08-15 Azevan Pharmaceuticals Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
KR102278197B1 (en) 2016-12-14 2021-07-15 베이징 서우바이 파마슈티컬 컴퍼니 리미티드 Bifunctional compound of quaternary ammonium salt structure
CN111295373A (en) 2017-09-15 2020-06-16 阿泽凡药物公司 Compositions and methods for treating brain injury

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI97540C (en) * 1989-11-06 1997-01-10 Sanofi Sa Process for the preparation of therapeutically useful aromatically substituted piperidine and piperazine derivatives
FR2666185B1 (en) * 1990-08-21 1992-12-04 Sgs Thomson Microelectronics INTERPOLATION ANALOG / DIGITAL CONVERTER.
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0591040A1 (en) 1994-04-06
ES2130238T3 (en) 1999-07-01
HU9302770D0 (en) 1993-12-28
HUT65759A (en) 1994-07-28
FI934273A (en) 1994-03-31
NZ248821A (en) 1995-10-26
SI9300513B (en) 2002-02-28
NO933481L (en) 1994-04-05
DE69323375D1 (en) 1999-03-18
HU211889A9 (en) 1995-12-28
KR940007026A (en) 1994-04-26
EP0591040B1 (en) 1999-02-03
AU674875B2 (en) 1997-01-16
CZ287272B6 (en) 2000-10-11
FI934273A0 (en) 1993-09-29
RU2120436C1 (en) 1998-10-20
CA2107432A1 (en) 1994-03-31
MX9306024A (en) 1994-03-31
NO933481D0 (en) 1993-09-29
GR3030000T3 (en) 1999-07-30
CA2107432C (en) 2000-04-04
OA09869A (en) 1994-08-15
JPH06211850A (en) 1994-08-02
SG47807A1 (en) 1998-04-17
CZ203593A3 (en) 1994-04-13
DK0591040T3 (en) 1999-09-20
JP3243212B2 (en) 2002-01-07
HU215848B (en) 1999-04-28
CN1088582A (en) 1994-06-29
AU4870893A (en) 1994-04-14
FR2696178A1 (en) 1994-04-01
ATE176469T1 (en) 1999-02-15
TW242625B (en) 1995-03-11
JPH10175976A (en) 1998-06-30
JP2857041B2 (en) 1999-02-10
BR9303982A (en) 1994-10-25
MY108881A (en) 1996-11-30
FI114474B (en) 2004-10-29
SI9300513A (en) 1994-06-30
DE69323375T2 (en) 1999-06-24
FR2696178B1 (en) 1994-12-30
CN1036652C (en) 1997-12-10
ZA937276B (en) 1994-04-25
IL107158A0 (en) 1993-12-28
KR100279084B1 (en) 2001-01-15

Similar Documents

Publication Publication Date Title
NO304888B1 (en) Quaternary basic amides and pharmaceutical mixtures containing them
RU93055131A (en) QUARTERLY AMIDES OF BASIC CHARACTER, METHOD OF THEIR PRODUCTION AND CONTAINING THEIR PHARMACEUTICAL COMPOSITION
NO933455L (en) Bis-naphthalimides containing amino acid-derived linkers, for use as anticancer agents
WO1990004918A3 (en) Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
GB2193633B (en) Psycho-active pharmaceutical compositions containing indolyl derivatives
LV5749B4 (en) Pharmaceutical composition containing cyclosporins
SG64368A1 (en) Dermorphin analogs their methods of preparation pharmaceutical compositions and methods of therapeutic treatment using the same
FR2613624B1 (en) ORAL ADMINISTRATIVE PHARMACEUTICAL COMPOSITION FOR REDUCING THE EFFECTS OF B-LACTAMINES
DK0562956T3 (en) New Naphthylalkylamines, Methods of Preparation and Pharmaceutical Agents Containing Them
IT1150213B (en) BIOAVAILABLE IRON DERIVATIVES FREE FROM GASTROLESIVITY, PREPARATION PROCEDURE AND RELATED PHARMACEUTICAL COMPOSITIONS
IE893653L (en) Compositions and compounds
DE3269309D1 (en) Pyrrolo(2,3-d)carbazole derivatives, preparation thereof and their therapeutical use
IL87444A0 (en) Pharmaceutical compositions containing polyaromatic compounds
AU2215483A (en) Pharmaceutical n-alkyl-(3 or 4)-piperidinyl benzoate derivatives
IL86096A0 (en) Extended release pharmaceutical compositions containing cholinergic amines
IT1215441B (en) PHARMACEUTICAL COMPOSITIONS SPASMOLITHIC ADAPTITY CONTAINING AS A PRINCIPLE ACTIO IDANPRAMINA
IL85265A0 (en) Pharmaceutical compositions containing polyaromatic compounds
IL83392A0 (en) Pharmaceutical compositions containing polyaromatic compounds
ZA922252B (en) Bis-Naphthalimides containing amino acid derived linkers as anticancer agents

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees